Find uplifting stories about heroes, innovations, and solutions
6305 results for "fda drug approval"
The FDA just greenlit both a new drug and a new vaccine, marking a milestone week for medical innovation. These back-to-back approvals give patients more options and show the pace of scientific progress.
Millions of Alzheimer's patients who experience severe agitation now have a safer treatment option after the FDA approved Auvelity, a drug that works differently than risky antipsychotic medications. The approval gives hope to families struggling with one of the disease's most challenging symptoms.
After years of setbacks, a new treatment for advanced melanoma just won FDA approval, giving patients a powerful option when other therapies have failed. The drug could help thousands facing one of the deadliest forms of skin cancer.
Dogs with lymphoma finally have treatments designed just for them. Two new FDA-approved drugs are giving veterinarians powerful, proven tools to fight one of the most common cancers in dogs.
Adults battling multiple myeloma just gained a powerful new weapon in their fight. The FDA has approved Zenbexus, the first drug in an entirely new class of treatments for this incurable blood cancer.
A groundbreaking treatment for triple-negative breast cancer just got FDA approval, giving patients twice as long with controlled disease and six more months of life. Christina, who could barely walk months ago, just walked down the aisle at a wedding thanks to this drug.
Patients battling a rare and stubborn blood cancer just gained a powerful new option after the FDA approved the first drug in its class to treat mantle cell lymphoma. The daily pill offers hope for patients who've exhausted other treatments, with trial results showing responses lasting over a year.
A breakthrough lung cancer treatment targeting a rare genetic mutation just won FDA approval two months ahead of schedule. The drug offers new hope for younger patients, often in their 40s and 50s, whose cancer stopped responding to earlier treatments.
A simpler HIV treatment just earned FDA approval, giving doctors a new option for patients managing the virus alongside other health conditions. The once-daily pill combines two drugs instead of three, offering hope for people juggling multiple medications.
A groundbreaking two-drug treatment just got FDA approval that could help thousands of kidney cancer patients stay cancer-free after surgery. The combination reduced the risk of cancer returning by 28% compared to standard treatment.
A groundbreaking new cancer treatment just became available for multiple myeloma patients facing their first relapse, doubling the chances of achieving the deepest level of cancer response. The FDA approved ZENBEXUS, the first drug in an entirely new treatment class that could transform how doctors fight this blood cancer.
The FDA just approved Denali Therapeutics' new medicine for Hunter syndrome, bringing fresh hope to families affected by this rare genetic disease. The approval comes as a welcome surprise after the agency recently toughened its standards for rare disease treatments.
A husband-and-wife research team turned their midnight lab conversations at the University of Virginia into ziftomenib, a newly FDA-approved drug now saving lives of leukemia patients who had run out of options. Their 17-year journey from academic research to life-saving treatment shows how university labs can tackle diseases others overlook.
People with a rare lung disease now have access to a more affordable treatment option after the FDA approved the first generic version of a life-changing medication. The new approval could help thousands of patients breathe easier, both physically and financially.
A heart condition once called a death sentence now has multiple FDA-approved treatments that are keeping patients alive and out of hospitals. Cardiac amyloidosis patients are being diagnosed earlier and living longer thanks to breakthrough medications approved in the past year.
The FDA just approved teplizumab for children aged 8 and older with stage 3 type 1 diabetes, expanding treatment options for young patients. This marks an important step forward in managing a disease that affects over 300,000 American children.
The FDA just approved Beqalzi, the first BCL2 inhibitor for patients with relapsed mantle cell lymphoma who've tried other treatments. Over half the patients in trials responded to the new therapy, offering fresh hope for those with limited options.
Children with Hunter syndrome now have access to the first treatment that reaches the brain, addressing complications that existing therapies couldn't touch. The FDA approval opens doors for treating dozens of other neurological conditions.
A groundbreaking protein-degrading therapy developed at Yale just became the first of its kind approved by the FDA to treat an aggressive form of breast cancer. The once-daily pill offers new hope for thousands of women facing estrogen receptor-positive metastatic breast cancer.
Alzheimer's patients struggling with agitation finally have a gentler treatment option that won't leave them drowsy or harm their hearts. The FDA just approved Auvelity, offering hope to millions of families navigating one of the disease's most challenging symptoms.
Showing 20 of 6305